The liver-cardiovascular disease connection is well-documented in the literature, and our findings revealed multiple indicators of impaired hepatic clearance capacity, including abnormalities in liver metabolites, elevated liver function markers (ALT and LDH), and decreased bilirubin levels. Here, GPT is linked to cardiovascular disorder.